HRT Financial
POM icon

HRT Financial’s POMDOCTOR LIMITED Class A Ordinary Shares POM Stock Holding History

HRT Financial’s Portfolio POM Stock Details POM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,233
Closed -$17K – 5055
2025
Q4 		$17K Buy
+3,233
New +$211K ﹤0.01% 3007

Other funds holding POM

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
XTX Topco
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Two Sigma Securities
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return
Virtu Financial
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $43.4M AUM 20.78% 1-Year Est. Return
Steward Partners Investment Advisory
Steward Partners Investment Advisory New York $21.5B AUM 22.23% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return

HRT Financial's POM Position: Q1 2026 in Review

HRT Financial sold out of POMDOCTOR LIMITED Class A Ordinary Shares (POM) in Q1 2026, closing a stake of 3,233 shares — an estimated $17K sold.

HRT Financial first reported a position in POM in Q4 2025 and held it in 1 quarter. The position peaked at $17K in Q4 2025. 10 funds tracked by Wall St. Rank hold POM as of Q1 2026.

  • HRT Financial reported no remaining POMDOCTOR LIMITED Class A Ordinary Shares position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 3,233 POMDOCTOR LIMITED Class A Ordinary Shares shares in Q1 2026, an estimated $17K.
  • HRT Financial first reported a position in POMDOCTOR LIMITED Class A Ordinary Shares in Q4 2025 and held it in 1 quarter.
  • HRT Financial's POMDOCTOR LIMITED Class A Ordinary Shares position peaked at $17K in Q4 2025.
  • 10 funds tracked by Wall St. Rank held POMDOCTOR LIMITED Class A Ordinary Shares as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.